SCHEMBL23818712

SCHEMBL23818712

CCCOC(=O)[C@H](C)NCOC[C@@]1(C#N)O[C@@H](c2ccc3c(N)ncnn23)[C@H](OC(=O)C(C)C)[C@@H]1OC(=O)C(C)C

nearest known ligand 0.38

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ POLRMT O00411 1/20 0.33
▸ RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23818571 0.96 POLRMT (0.32) POLRMT
SCHEMBL23818863 0.94 POLRMT (0.33) POLRMT
SCHEMBL23818894 0.94 POLRMT (0.34) POLRMTRIPK1
SCHEMBL23818443 0.92 POLRMT (0.33) POLRMT
SCHEMBL23819067 0.92 POLRMT (0.32) POLRMT
SCHEMBL23818565 0.91 POLRMT (0.33) POLRMT
SCHEMBL23818871 0.91 POLRMT (0.32) POLRMT
SCHEMBL23819095 0.90 POLRMT (0.32) POLRMT
SCHEMBL23819149 0.90 POLRMT (0.32) POLRMT
SCHEMBL26333067 0.90 POLRMT (0.32) POLRMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 — — US disclosed
US-20210284670-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284670-A1 ANTIVIRAL COMPOUNDS MAVS, HAVCR2, ZC3HAV1 POLRMT 535/4885RIPK1 666/4885
US-11767337-B2 Antiviral compounds MAVS, HAVCR2, ZC3HAV1 POLRMT 535/4885RIPK1 666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback